From

Institution

Field

Type

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers matching “CTLA-4” 44

Sort: Relevance Cited Newest Oldest Fwci Patents ⇩ CSV

Not finding it? Sign in to also search OpenAlex live.

Zoledronate decreases CTLA-4 in vivo and in vitro independently of its action on bone resorption
2020 Bone article Medicine Bone health and treatments

Andrea Giusti, Dario Camellino, Danièle Saverino, Erika Iervasi, Giuseppe Girasole, Gerolamo Bianchi, +1 more

9

citations
Management of Autoimmune Encephalitis in a 7-Year-Old Child With CTLA-4 Haploinsufficiency and AMPA Receptor Antibodies
2024 Neurology Neuroimmunology & Neuroinflammation article Medicine Autoimmune Neurological Disorders and Treatments Open access

Marjolijn S.W. Quaak, Michiel S.J.S. Buijze, Virginie J. M. Verhoeven, Clementien L. Vermont, Emilie P. Buddingh, Maud Heredia, +5 more

6

citations
PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice
2024 Journal of Clinical Investigation article Medicine Cancer Immunotherapy and Biomarkers Open access

Elselien Frijlink, Douwe M. T. Bosma, Julia Busselaar, Thomas Battaglia, Mo D. Staal, Inge Verbrugge, +1 more

36

citations
Brief Communication: Treatment Outcomes for Advanced Melanoma of Unknown Primary Compared With Melanoma With Known Primary
2024 Journal of Immunotherapy article Medicine Cutaneous Melanoma Detection and Management

Oana‐Diana Persa, J.C. Hassel, Theresa Steeb, Michael A. Erdmann, Bita Karimi, Henner M. Stege, +7 more

6

citations
TIGIT drives the immunosuppressive environment by downregulation of metalloproteinases MMP2 and MMP14 in perihilar cholangiocarcinoma
2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access

Lara Rosaline Heij, Konrad Reichel, Willem de Koning, Jan Bednarsch, Xiuxiang Tan, Julia Campello Deierl, +13 more

0

citations
25Transcriptome profiling identifies TIGIT and PD-1 co-expression in the immunosuppressive environment in cholangiocarcinoma
2026 The Oncologist article Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access

Lara Rosaline Heij, Sikander Hayat, Konrad Reichel, Sidrah Maryam, Juan Jesús García-Vallejo, Danny David Jonigk, +5 more

0

citations
Abstract CT194: Low-dose Interferon-alpha pre-conditioning and adoptive cell therapy in metastatic melanoma patients refractory to standard (immune) therapies - a phase 1/2 study
2020 Cancer Research conference-abstract Medicine Cancer Immunotherapy and Biomarkers

Monique K. van der Kooij, Els M.E. Verdegaal, Marten Visser, Carolien E. van der Minne, Linda de Bruin, Pauline Meij, +8 more

0

citations
Tolerance–resistance continuum in immune checkpoint pathways: molecular architecture, spatial niches and clinical consequences
2026 BMJ Immunology article Medicine Cancer Immunotherapy and Biomarkers

Henry Sutanto, Deasy Fetarayani, Betty Rachma, Jefferson Caesario

0

citations
Artificial Intelligence–Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti–PD-1–Based Treated Melanoma
2025 JAMA Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access

Mark Schuiveling, Isabella A.J. van Duin, Laurens S. ter Maat, Janneke C. van der Weerd, Rik Jasper Verheijden, Franchette W.P.J. van den Berkmortel, +18 more

9

citations
Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients
2021 Hepatology International article Medicine Cancer Immunotherapy and Biomarkers Open access

Maaike Biewenga, Monique K. van der Kooij, Michel W.J.M. Wouters, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Jan Willem B. de Groot, +12 more

39

citations
Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence
2024 International Journal of Molecular Sciences article Medicine Cancer Immunotherapy and Biomarkers Open access

Abdulaziz M. Eshaq, Thomas Wayne Flanagan, Abdulqader Ali Ba Abbad, Zain Alabden A. Makarem, Mohammed S. Bokir, Ahmed Khaled Alasheq, +8 more

20

citations
Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease
2020 Frontiers in Immunology article Medicine Hemoglobinopathies and Related Disorders Open access

Karina Tozatto‐Maio, Robert Girot, Indou Deme Ly, Ana Cristina Silva Pinto, Vanderson Rocha, Francisco Fernandes, +22 more

23

citations
Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy
2023 Cells article Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access

Lara Rosaline Heij, Jan Bednarsch, Xiuxiang Tan, Mika Rosin, Simone Appinger, Konrad Reichel, +10 more

20

citations
Local administration of immunotherapy for patients with skin cancer: A systematic review
2024 Cancer Treatment Reviews review Medicine Cancer Immunotherapy and Biomarkers Open access

Brigit van Dijk, Lotte L. Hoeijmakers, Dirk Jan Grünhagen, Wichor Matthijs Bramer, Cornelis Kees Verhoef, Tanja D. de Gruijl, +2 more

12

citations
Current status of immunotherapy in gastrointestinal malignancies
2020 Zeitschrift für Gastroenterologie article Medicine Cancer Immunotherapy and Biomarkers

Sylvie Lorenzen, Florian Lordick, Sven Heiko Loosen, Frank Tacke, Christian Trautwein, Christoph Roderburg, +4 more

6

citations
Immune‐based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
2020 HemaSphere article Medicine Cancer Immunotherapy and Biomarkers Open access

Hermann Einsele, Javier Briones, Fabio Ciceri, Irene García‐Cadenas, Fred Falkenburg, Natacha Bolaños, +10 more

5

citations
Editorial: “The Role of Immune Checkpoint Molecules in Solid and Hematopoietic Stem Cell Transplantation”
2021 Frontiers in Immunology editorial Medicine Cancer Immunotherapy and Biomarkers Open access

Lambros Kordelas, Frans H.J. Claas, Vera Rebmann

1

citations
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma
2024 Immuno-Oncology Technology article Medicine Cancer Immunotherapy and Biomarkers Open access

Isabella A.J. van Duin, Mark Schuiveling, Laurens S. ter Maat, Mitko Veta, Mick J M van Eijs, Rik Jasper Verheijden, +13 more

2

citations
Nebenwirkungen neuer onkologischer Immuntherapien
2020 Der Nephrologe article Medicine Cancer Immunotherapy and Biomarkers Open access

Gerald S. Braun, Martin Kirschner, Albert Rübben, Renate Ursula Wahl, Kerstin Amann, Karolina Benesova, +1 more

13

citations
Behavioral factors to modulate immunotherapy efficacy in cancer
2022 Frontiers in Immunology article Medicine Cancer Immunotherapy and Biomarkers Open access

Chiara Jongerius, Louis Vermeulen, Marjolein van Egmond, Andrea W.M. Evers, Laurien M. Buffart, Kristiaan Lenos

9

citations
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
2024 New England Journal of Medicine article Medicine Cutaneous Melanoma Detection and Management Open access

Christian U Blank, Minke W Lucas, Richard A. Scolyer, Bart A. van de Wiel, Alexander Maxwell Menzies, Marta López‐Yurda, +62 more

538

citations
Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem
2021 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

Kikkie Poels, Suzanne I.M. Neppelenbroek, Marie José Kersten, M. Louisa Antoni, Esther Lutgens, Tom T. P. Seijkens

61

citations
Dual Immune Checkpoint Blockade Induces Analogous Alterations in the Dysfunctional CD8+ T-cell and Activated Treg Compartment
2023 Cancer Discovery article Medicine Cancer Immunotherapy and Biomarkers Open access

Anne M. van der Leun, Joleen J.H. Traets, Joris L. Vos, Joris B.W. Elbers, Sanne Patiwael, Xiaohang Qiao, +5 more

45

citations
Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial
2022 The Lancet Healthy Longevity article Medicine Cancer Immunotherapy and Biomarkers Open access

Matthias P A Ebert, Nadja M. Meindl‐Beinker, Tobias Gutting, Martin Maenz, Johannes Betge, Nadine Schulte, +16 more

31

citations
Pleural mesothelioma
2025 Nature Reviews Disease Primers review Medicine Occupational and environmental lung diseases

Dean Anthony Fennell, Yoshitaka Sekido, Paul Baas, Aliya Noor Husain, Alessandra Curioni Fontecedro, Eric Lim, +4 more

30

citations